XML 50 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
BUSINESS SEGMENT INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2017
Segment Reporting [Abstract]  
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
Products are sold principally to wholesalers, and to a lesser extent, directly to distributors, retailers, hospitals, clinics, government agencies and pharmacies. Gross revenues to the three largest pharmaceutical wholesalers in the U.S. as a percentage of global gross revenues were as follows:
 
 
2017
 
2016
 
2015
McKesson Corporation
 
24
%
 
22
%
 
21
%
AmerisourceBergen Corporation
 
18
%
 
18
%
 
16
%
Cardinal Health, Inc.
 
15
%
 
14
%
 
12
%
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Selected geographic area information was as follows:
 
 
Revenues
 
Property, Plant and Equipment
Dollars in Millions
 
2017
 
2016
 
2015
 
2017
 
2016
United States
 
$
11,358

 
$
10,720

 
$
8,188

 
$
3,617

 
$
3,865

Europe
 
4,988

 
4,215

 
3,491

 
1,266

 
1,003

Rest of the World(a)
 
3,877

 
3,964

 
4,142

 
118

 
112

Other(b) 
 
553

 
528

 
739

 
—

 
—

Total
 
$
20,776

 
$
19,427

 
$
16,560

 
$
5,001

 
$
4,980

(a)
Includes Japan which represented 7%, 7% and 10% of total revenues in 2017, 2016 and 2015, respectively.
(b)
Other revenues include royalties and alliance-related revenues for products not sold by our regional commercial organizations.
Schedule of Revenue from External Customers by Products and Services [Table Text Block]
Product revenues and the composition of total revenues were as follows:
 
 
Year Ended December 31,
Dollars in Millions
 
2017
 
2016
 
2015
Prioritized Brands
 
 
 
 
 
 
Opdivo
 
$
4,948

 
$
3,774

 
$
942

Eliquis
 
4,872

 
3,343

 
1,860

Orencia
 
2,479

 
2,265

 
1,885

Sprycel
 
2,005

 
1,824

 
1,620

Yervoy
 
1,244

 
1,053

 
1,126

Empliciti
 
231

 
150

 
3

Established Brands
 
 
 
 
 
 
Baraclude
 
1,052

 
1,192

 
1,312

Sustiva Franchise
 
729

 
1,065

 
1,252

Reyataz Franchise
 
698

 
912

 
1,139

Hepatitis C Franchise
 
406

 
1,578

 
1,603

Other Brands
 
2,112

 
2,271

 
3,818

Total Revenues
 
$
20,776

 
$
19,427

 
$
16,560

 
 
 
 
 
 
 
Net product sales
 
$
19,258

 
$
17,702

 
$
14,045

Alliance revenues
 
1,294

 
1,629

 
2,408

Other revenues
 
224

 
96

 
107

Total Revenues
 
$
20,776

 
$
19,427

 
$
16,560